Established in the year 1924 in India, GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 4500 people. Globally, the company is a £ 26.5 billion (US$ 41.28 billion), leading, research-based healthcare and pharmaceutical company.
The GSK India product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The company is the market leader in most of the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others.
GSK India: Leading Indian Biotechnology Company
|2014||Gets named as one of 'India's Most Admired Companies' by Fortune India in partnership with the Hays Group|
|2012||Receives the Paediatrician's Award for the Best Vaccine Company of the Year by Frost & Sullivan|
|2011||Unveils Synflorix - a vaccine against invasive pneumococcal disease|
|2010||Launches Mycamine, an injectible antifungal drug in-licensed from Astellas, Japan|
|2009||Commences Albendazole production in Nashik to treat Lymphatic Filariasis|
Updated: December, 2014